284 related articles for article (PubMed ID: 15916817)
41. Antiviral activity of pyridyl imidazolidinones against enterovirus 71 variants.
Chen TC; Liu SC; Huang PN; Chang HY; Chern JH; Shih SR
J Biomed Sci; 2008 May; 15(3):291-300. PubMed ID: 18196474
[TBL] [Abstract][Full Text] [Related]
42. Rupintrivir is a promising candidate for treating severe cases of enterovirus-71 infection: evaluation of antiviral efficacy in a murine infection model.
Zhang X; Song Z; Qin B; Zhang X; Chen L; Hu Y; Yuan Z
Antiviral Res; 2013 Mar; 97(3):264-9. PubMed ID: 23295352
[TBL] [Abstract][Full Text] [Related]
43. Formononetin inhibits enterovirus 71 replication by regulating COX- 2/PGE₂ expression.
Wang H; Zhang D; Ge M; Li Z; Jiang J; Li Y
Virol J; 2015 Mar; 12():35. PubMed ID: 25890183
[TBL] [Abstract][Full Text] [Related]
44. Bovine lactoferrin prevents the entry and intercellular spread of herpes simplex virus type 1 in Green Monkey Kidney cells.
Ammendolia MG; Marchetti M; Superti F
Antiviral Res; 2007 Dec; 76(3):252-62. PubMed ID: 17881064
[TBL] [Abstract][Full Text] [Related]
45. Anti-HSV activity of lactoferrin and lactoferricin is dependent on the presence of heparan sulphate at the cell surface.
Andersen JH; Jenssen H; Sandvik K; Gutteberg TJ
J Med Virol; 2004 Oct; 74(2):262-71. PubMed ID: 15332275
[TBL] [Abstract][Full Text] [Related]
46. Enterovirus 71 infection induces Fas ligand expression and apoptosis of Jurkat cells.
Chen LC; Shyu HW; Chen SH; Lei HY; Yu CK; Yeh TM
J Med Virol; 2006 Jun; 78(6):780-6. PubMed ID: 16628611
[TBL] [Abstract][Full Text] [Related]
47. A bifunctional anti-enterovirus compound that inhibits replication and the early stage of enterovirus 71 infection.
Arita M; Takebe Y; Wakita T; Shimizu H
J Gen Virol; 2010 Nov; 91(Pt 11):2734-44. PubMed ID: 20660150
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of herpes simplex virus infection by lactoferrin is dependent on interference with the virus binding to glycosaminoglycans.
Marchetti M; Trybala E; Superti F; Johansson M; Bergström T
Virology; 2004 Jan; 318(1):405-13. PubMed ID: 14972565
[TBL] [Abstract][Full Text] [Related]
49. Development of poly(ethylene glycol) conjugated lactoferrin for oral administration.
Nojima Y; Suzuki Y; Iguchi K; Shiga T; Iwata A; Fujimoto T; Yoshida K; Shimizu H; Takeuchi T; Sato A
Bioconjug Chem; 2008 Nov; 19(11):2253-9. PubMed ID: 18834167
[TBL] [Abstract][Full Text] [Related]
50. Outbreak of neurologic enterovirus type 71 disease: a diagnostic challenge.
Pérez-Vélez CM; Anderson MS; Robinson CC; McFarland EJ; Nix WA; Pallansch MA; Oberste MS; Glodé MP
Clin Infect Dis; 2007 Oct; 45(8):950-7. PubMed ID: 17879907
[TBL] [Abstract][Full Text] [Related]
51. Antiviral activity of punicalagin toward human enterovirus 71 in vitro and in vivo.
Yang Y; Xiu J; Zhang L; Qin C; Liu J
Phytomedicine; 2012 Dec; 20(1):67-70. PubMed ID: 23146421
[TBL] [Abstract][Full Text] [Related]
52. Enterovirus 71 infection of human dendritic cells.
Lin YW; Wang SW; Tung YY; Chen SH
Exp Biol Med (Maywood); 2009 Oct; 234(10):1166-73. PubMed ID: 19596831
[TBL] [Abstract][Full Text] [Related]
53. Bovine lactoferrin digested with human gastrointestinal enzymes inhibits replication of human echovirus 5 in cell culture.
Furlund CB; Kristoffersen AB; Devold TG; Vegarud GE; Jonassen CM
Nutr Res; 2012 Jul; 32(7):503-13. PubMed ID: 22901558
[TBL] [Abstract][Full Text] [Related]
54. In vitro inhibition of enterovirus 71 infection with a nickel ion/chitosan microcomposite.
Lin YC; Chang CH
Virus Res; 2014 Sep; 190():17-24. PubMed ID: 24998885
[TBL] [Abstract][Full Text] [Related]
55. [Autophagy inhibitor 3-MA decreases the production and release of infectious enterovirus 71 particles].
Zhang XY; Xi XY; Zhao ZD
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Jun; 25(3):176-8. PubMed ID: 21977584
[TBL] [Abstract][Full Text] [Related]
56. Sheng-Ma-Ge-Gen-Tang inhibited Enterovirus 71 infection in human foreskin fibroblast cell line.
Chang JS; Wang KC; Chiang LC
J Ethnopharmacol; 2008 Sep; 119(1):104-8. PubMed ID: 18601992
[TBL] [Abstract][Full Text] [Related]
57. In vitro and in vivo protection against enterovirus 71 by an antisense phosphorothioate oligonucleotide.
Liu J; Zhou Z; Li K; Han M; Yang J; Wang S
Arch Virol; 2014 Sep; 159(9):2339-47. PubMed ID: 24756344
[TBL] [Abstract][Full Text] [Related]
58. Role of endogenous interferon and LPS in the immunomodulatory effects of bovine lactoferrin in murine peritoneal macrophages.
Puddu P; Carollo MG; Belardelli F; Valenti P; Gessani S
J Leukoc Biol; 2007 Aug; 82(2):347-53. PubMed ID: 17475783
[TBL] [Abstract][Full Text] [Related]
59. Release of surface-expressed lactoferrin from polymorphonuclear neutrophils after contact with CD4+ T cells and its modulation on Th1/Th2 cytokine production.
Li KJ; Lu MC; Hsieh SC; Wu CH; Yu HS; Tsai CY; Yu CL
J Leukoc Biol; 2006 Aug; 80(2):350-8. PubMed ID: 16769765
[TBL] [Abstract][Full Text] [Related]
60. Bovine lactoferrin inhibits Japanese encephalitis virus by binding to heparan sulfate and receptor for low density lipoprotein.
Chien YJ; Chen WJ; Hsu WL; Chiou SS
Virology; 2008 Sep; 379(1):143-51. PubMed ID: 18640695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
